A Fruitful Holiday Week

Closing Out the Short Week 

We hope everyone had a safe and happy holiday. We’re ready to close out this short trading week with a half day today. Just before we broke for Thanksgiving, we produced some fresh options ideas to carry into the end of the week.

Among those plays were the JWN Weekly $24-26 Calls and the GPS Weekly $24.50-23.50 Puts, and we observed some pretty good moves from those plays on Wednesday:

JWN Weekly $24-26 Calls
: 1.40-5.45 (+289%)
$25: .70-4.47 (+539%)
$26: .38-3.50 (+821%)

GPS Weekly $24.50-23.50 Puts
: 1.80-3.10 (+72%)
$24: 1.13-3.69 (+227%)
$23.50: 1.08-2.06 (+91%)

Fresh Options Ideas: 
CGC Weekly $26-27 Calls
X Weekly $14-15 Calls

Extended Watchlist:

More Multi-bag Options Runners

CURE Pharmaceutical Holding Corp. CURR

We find CURR very interesting because of the company’s unique systems/methods for delivering drugs into the human body. It’s not often that we run into an OTC traded play with intriguing proprietary technologies.

The Company’s efforts to further position itself as an integrated healthcare company with its recent acquisition of The Sera Labs, a high-margin, multi-channel marketing and branding company with accelerating sales of its more than 20 products in the health & wellness, beauty, and pets categories and strong traction in both e-commerce and wholesale-to-retail distribution with total retail doors exceeding 8,850 in the U.S. to date. CURE acquired 100 percent of privately held The Sera Labs for $20 million, which consists primarily of stock with key earn out considerations totaling up to an additional $20 million within two years of completing the acquisition.

The Sera Labs newest consumer product that uses CURE’s patented and advanced oral thin film strip technology under the trademark name Nutri-Strips with RAD3 (Rapid Activation Delivery) to deliver novel vitamins and supplements to consumers across the nation.

The Company’s future plans and focus on research and development into CURE’s pharmaceutical programs and The Sera Labs commitment to innovating its offerings with a “tele-wellness” program and exciting new products.

In addition to an interesting backstory the CURR chart itself looks rather attractive at the moment. The stock has just bounced off of its 52-week low, with a recent increase in volume. The PPS over the last two sessions has held a higher low, so we’ll be looking for the further establishment of higher highs and higher lows off of its bottom. Key resistance points to note are the 50DMA at 1.22 and the 200DMA at 1.73. We are definitely going to put this play on our watchlist this today and continue to track its progress going forward.

Options Recaps

We had a clean sweep on options in yesterday’s report, with each of the three sets of ideas we offered up to our readers performed quite well on the day. Here are the ranges and total potential intraday gains that were on the table:

DLTR Weekly $104-106 Calls
: 2.38-8.11 (+241%)
$105: 1.94-6.94 (+258%)
$106: 1.03-6.45 (+526%)

AMBA Weekly $68.50-70 Calls
: 3.28-6.50 (+98%)
$69: 2.20-7.20 (+227%)
$70: 1.55-6.39 (+312%)

NTNX Weekly $30-32 Calls 
$30: .50-1.11 (+222%)
$31: .24-.60 (+250%)
$32: .05-.30 (+500%)

Fresh Options Ideas: 
JWN Weekly $24-26 Calls*
DE Weekly $265-270 Calls*
GAP Weekly $24.50-23.50 Puts*

*Please note that these weekly contracts will expire early on Friday at the 1PM close, following tomorrow’s holiday. We hope everyone has a safe and happy Thanksgiving!

Extended Watchlist:

INO Update & More

Inovio Pharmaceuticals, Inc. INO 

We signaled INO on Thursday morning, and this week, the stock has enjoyed some really solid activity, which facilitated the chance at a big gain for traders. We have observed a range of 3.83-7.48 in just a couple of sessions. That works out to total potential profit of 95%

It was a buck of the overall trend as many of these pharma plays have been doing through the coronavirus scare currently in progress. While the markets got a momentary boost from the Fed’s surprise rate cut yesterday, it was not long-lived, and the decline for other stocks continued throughout the majority of the session.

This morning, the stock has hit 8.80 in the premarket, extending our observed gain this week to 130%

While world governments rush to contain the spread of the virus, it would not yet be accurate to call it under control. We would expect much more hardship on the day-to-day for stocks before we’re out of the woods. So plays like INO are a welcome respite during this tumultuous time, and we’ll do our best to keep them coming.

Fresh Options Ideas 
CPB Weekly $49-50.50 Calls
JWN Weekly $32.50-30 Puts

Extended Watchlist: